
Sign up to save your podcasts
Or
In this week’s podcast, Neurology Today’s editor-in-chief discusses the approval of fenfluramine for Lennox-Gastaut syndrome, how social isolation affects dementia risk, and the competitiveness of neurology in this year’s residency match.
4.7
1919 ratings
In this week’s podcast, Neurology Today’s editor-in-chief discusses the approval of fenfluramine for Lennox-Gastaut syndrome, how social isolation affects dementia risk, and the competitiveness of neurology in this year’s residency match.
291 Listeners
315 Listeners
47 Listeners
865 Listeners
496 Listeners
13 Listeners
90 Listeners
26 Listeners
517 Listeners
132 Listeners
350 Listeners
182 Listeners
366 Listeners
5 Listeners
78 Listeners